In a variety of carcinomas, we and the others have demonstrated that CPH exhibits significant anti-tumor activity through multiple pathways (Jou et al. 2021; Feng et al. 2012; Hsieh et al. 2017). The gene discussed is CPE; the disease is carcinoma.